In summary, knocking down lncRNA-NEAT1 can inhibit T lymphocyte activation and interleukin production, improve psoriasis symptoms, and provide possibilities for experimental research on lncRNA-NEAT1 inhibitors. The gene discussed is NEAT1; the disease is psoriasis.